¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Disease, Gaucher type 1"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • hemorrhagic disease
    ÃâÇ÷º´
  • hepatolenticular disease
    °£·»ÁîÇÙº´
  • hereditary disease
    À¯Àüº´
  • heredodegenerative disease
    À¯Àüº¯¼ºº´
  • herpetic disease
    Ç츣Æä½ºº´
  • hidebound disease
    Çǰñ»óÁ¢º´
  • hip-joint disease
    ¾ûµ¢°üÀýº´, °í°üÀýº´
  • Hirschsprung¡¯s disease
    È÷¸£½´½´ÇÁ·îº´
  • hand-foot-mouth disease
    ¼Õ¹ßÀÔº´
  • Hand-Schuller-Christian disease
    ÇÚµå-½¯·¯-Å©¸®½ºÃµº´
  • Hodgkin¡¯s disease
    È£ÁöŲº´
  • holoendemic disease
    ¼Ò¾ÆÇ³Å亴
  • hookworm disease
    ±¸Ã溴
  • Hansen¡¯s disease
    ÇѼ¾º´
  • hunger disease
    ±â¾Æº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • hemoglobin disease
    Çì¸ð±Û·Îºóº´, Ç÷»ö¼Òº´
  • hemolytic disease
    ¿ëÇ÷º´, ¿ëÇ÷Áúȯ
  • hemorrhagic disease
    ÃâÇ÷º´
  • hemp disease
    ¸¶¼¶À¯º´
  • hepatolenticular disease
    °£·»ÁîÇÙº´
  • hepatolienal disease
    °£Áö¶óº´, °£ºñÀ庴
  • hereditary disease
    À¯Àüº´
  • heredoconstitutional disease
    À¯ÀüüÁúº´
  • heredodegenerative disease
    À¯Àüº¯¼ºÁõ
  • herpetic disease
    Ç츣Æä½ºº´
  • hidebound disease
    (¢¡scleroderma) ÇǺΰæÈ­Áõ, ÇǺα»À½Áõ
  • hip-joint disease
    ¾ûµ¢°üÀýº´, °í°üÀýº´
  • holoendemic disease
    ¼Ò¾ÆÇ³Å亴
  • hookworm disease
    ±¸Ã溴
  • hunger disease
    ±â¾Æº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • Kahler s disease
    Ä®·¯º´.
  • Kawasaki disease
    °¡¿Í»ç³¢º´, Á¡¸·ÇǺθ²ÇÁÀý ÁõÈıº (±Þ¼º¿­¼º)
  • Kawasaki disease => mucocutaneous lymph node syndrome
    °¡¿Í»çŰ º´
  • Kimura disease
    ±â¹«¶ó º´
  • Krabbe s disease
    Å©¶óº£º´.
  • Krabbes disease
    Å©·¹º£º´
  • Kyrles disease = hyperkeratosis folliculitis
    ۸¦·¹ º´
  • Lebers disease
    ·¹º£¸£º´
  • Legionnaires disease
    ·¹±â¿À³Ú¶óÁõ, ÀçÇⱺÀÎȸº´
  • Leiners disease
    ¶óÀÌ³Ê º´
  • Lesch-Nyhan disease
    ¸®½´-´ÏÇѺ´
  • Letterer Siwe disease
    ·¹Å×·¯-½Ã¿þº´(~º´).
  • Letterer Siwe disease
    ·¹Å×·¯-½Ã¿þº´.
  • Lindaus disease
    ¸°µµ¿ìº´
  • Lutz s disease
    ·çÂ꺴.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • type III human T lymphotropic virus
    IIIÇü ÀÎ t¸²ÇÁ¿µ¾ç¼º ¹ÙÀÌ·¯½º
  • type a encephalitis
    ±â¸é¼º ³ú¿°(ÐîØùàõÒàæú)
  • type a spermatogonium
    À¸¶äÁ¤Á¶¼¼Æ÷
  • type b encephalitis =japanese e.
    BÇü ³ú¿°
  • type b spermatogonium
    ´ÊÁ¤Á¶¼¼Æ÷
  • type culture
    Ç¥Áعè¾ç
  • type culture
    ´ëÇ¥(±ÕÁ¾)¹è¾ç(ÓÛøúжðúÛÆå×), Ç¥Áعè¾ç(øöñÞÛÆå×).
  • type culture
    ´ëÇ¥(±ÕÁ¾)¹è¾ç(ÓÛøúжðúÛÆå×), Ç¥Áعè¾ç(øöñÞÛÆå×).
  • type culture collection
    Ç¥ÁرÕÁÖ¼ö·Ï(¡­Ð¶ñ»â¥ÒÓ).
  • type i hair cell
    Á¶·Õ¹ÚÅм¼Æ÷
  • type ii hair cell
    ¿øÁÖÅм¼Æ÷
  • type of respiration
    È£ÈíÇü(û¼ýåúþ).
  • type species
    Ç¥ÁرÕÁ¾(øöñÞжðú).
  • type specific antigen
    ÇüƯÀÌÇ׿ø
  • type specific polysaccharide
    ÇüƯÀ̼º ´Ù´ç·ù(úþ÷åì¶àõÒýӨ׾).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
GSD genetically significant dose; Gerstmann-Straussler disease; glutathione synthetase deficiency; glyco...
HLD hepatolenticular degeneration; herniated lumbar disk; Hippel-Lindau disease; hypersensitivity lung d...
IBD inflammatory bowel disease; irritable bowel disease
IPD idiopathic Parkinson disease; idiopathic protracted diarrhea; immediate pigment darkening; increase ...
KD cathodal duration; Kawasaki disease; Kennedy disease; killed
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
BPV-4 Bovine papillomavirus type 4
bPIV3 Bovine parainfluenza virus type 3
CNP C type natriuretic peptide
CAV-1 Canine adenovirus type 1
CAV-2 Canine adenovirus type 2
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Hansen's disease
    ÇѼ¾º´, ³ªº´
    ÁÖ·Î ÇÇºÎ¿Í ¸»ÃʽŰæÀ» ħ¹üÇÏ´Â ¸¸¼º À°¾ÆÁ¾¼º °¨¿°ÀÇ ÀÏÁ¾. Mycobacterium le
  • Hartnup disease
    Çϸ£Æ®´©ÇÁ º´
    À¯Àü¼º
  • Hashimoto's disease
    ÇϽø𵵠º´
    °©»ó¼±ÀÇ ÁøÇ༺ ÀÚ°¡ ¸é¿ª ÁúȯÀ¸·Î¼­ ¸²ÇÁ±¸ ħÀ±°ú ¼øÈ¯Áß ÀÚ°¡ Ç×ü¸¦ µ¿¹ÝÇÑ´Ù. ¿©ÀÚ¿¡°Ô Àß ÀϾ°í °¡°èÀû ¼ÒÀÎ °æÇâÀÌ ÀÖ´Ù. ¶§·Î´Â °©»ó¼± ±â´É Ç×ÁøÁõ¿¡ ÈļÓÇÏ¿© ³ªÅ¸³ª¸ç, ȯÀÚ´Â °©»ó¼± Á¾´ë¸¦ ÀÏÀ¸Å°°í Á¡ÁøÀûÀ¸·Î °©»ó¼± ±â´É ÀúÇÏ »óÅ¿¡ ºüÁø´Ù.
  • heart disease
    ½ÉÀå º´, ½É Áúȯ
    ¼øÈ¯±â Áúȯ Áß ½ÉÀåÀÇ Áúȯ. ÀϹÝÀûÀ¸·Î °ü Ç÷°üÀ̳ª ½ÉÀåÀÇ º´µµ Æ÷ÇԵȴÙ. º´º¯ÀÇ ºÎÀ§¿¡ ÀÇÇÑ º´¸®ÇغÎÇÐÀû ºÐ·ù¿Í º´Àο¡ ÀÇÇÑ ºÐ·ù°¡ ÀÌ·ç¾îÁö°í ÀÖ´Ù. ÀüÀÚ´Â ¼ö ½Ê ³â ÀüºÎÅÍ ¾²¿©Á® ¿ÔÀ¸³ª ±Ù³â¿¡ ¿Í¼­ º»ÁúÀûÀÎ ¿øÀÎ ¿ä¹ýÀÌ °¡´ÉÇÏ°Ô µÈ ÀÌÈÄ´Â ÈÄÀÚÀÇ ºÐ·ù°¡ ÀÇÀǰ¡ À־ ¸¹ÀÌ ¾²ÀÌ°Ô µÇ¾ú´Ù. º´º¯ ºÎÀ§·Î´Â ½É³»¸·
  • heavy chain disease
    H ¼âº´, Á߼⺴
    ´ÜŬ·Ð¼ºÀÇ °¨¸¶ ±Û·ÎºÒ¸° ÀÌ»óÀ¸·Î¼­, Ç׿ø¼º °áÁ¤ ÀÎÀÚ°¡ °á¿©µÈ ¸é¿ª ±Û·ÎºÒ¸°ÀÌ »ý»êµÈ´Ù.
  • hematologic disease
    Ç÷¾× Áúȯ
  • hematopoietic disease
    Á¶Ç÷ Áúȯ, Á¶Ç÷¼º Áúȯ
    Ç÷°üÀ̳ª Ç÷¾× ¼ººÐÀ» »ý¼ºÇÏ´Â µ¥ ÀÖ¾î ¹®Á¦¸¦ ÀÏÀ¸Å°´Â Áúº´.
  • hemic disease
    Ç÷¾× Áúȯ
  • hemolytic disease
    ¿ëÇ÷¼º Áúȯ
  • hepatocerebral disease
    °£ ³ú ÁõÈıº
    Àª½¼ º´°ú À̳뼼ÇüÀ¸·Î Å©°Ô ³ª´­ ¼ö ÀÖ´Ù. Àª½¼ º´Àº ¼±Ãµ¼ºÀÎ °áÇÔÀ¸·Î ÀÎÇÑ ±¸¸® ´ë»ç ÀÌ»óÀ¸·Î¼­, °£ ¹× ³ú¿¡ ´Ù·®ÀÇ ±¸¸®°¡ Ä§ÂøÇÑ´Ù. °£Àº ÇöÀúÇÑ °æº¯ÁõÀ» ³ªÅ¸³»°í, °£ ±â°£ºÎÀÇ ·»Áî ÇÙÀ̳ª Çǰ¢ µî¿¡ º¯¼ºÀÌ »ý±ä´Ù. ÇÇ, ¿ÀÁÜ ¼ÓÀÇ ±¸¸®´Â ºÒ¾î³ª³ª, Ç÷¾× ¼ÓÀÇ ±¸¸® °áÇÕ ´Ü¹éÁúÀÎ ¼¿·ê·Î Çö󽺹ÎÀº °¨¼ÒÇÏ°í °¢¸·¿¡ Ä«ÀÌÀú ÇöóÀ̼ŠȯÀÌ »ý±ä´Ù. À̳뼼Çü Áß °£ ¿ÜÇüÀº °£ Áúȯ ½Ã¿¡ °£ ³» Ç÷·ù°¡ °ï¶õÇÏ°Ô µÈ °á°ú, °£ ¿ÜÀÇ ´Ü¶ôÀ» ÅëÇÏ¿© ³»¸ÆÇ÷ÀÌ ±×´ë·Î ½ºÃÄ Áö³ª°¡±â ¶§¹®¿¡ Ç÷¾× ¼ÓÀÇ ¾Ï¸ð´Ï¾Æ °ªÀÌ »ó½ÂÇÏ¿© ³ú Áõ»óÀ» ÀÏÀ¸Å²´Ù. °£³»ÇüÀº ÁÖ·Î Áö¹æ¼º °£ °æº¯Áõ µî¿¡¼­ °£ ³»ÀÇ ´Ü¶ôÀ» ±×´ë·Î ºüÁ®³ª°¡±â ¶§¹®¿¡ À§¿Í °°Àº °á°ú¸¦ °¡Á®¿À´Â °ÍÀ» ¸»ÇÑ´Ù.
  • hereditary disease
    À¯Àüº´
    À¯ÀüÀÚ¿¡ ÀÇÇÏ¿© ÀϾ´Â ½ÅüÀû, Á¤½ÅÀûÀÎ ÀÌ»óÀÇ ÃÑĪ. À¯Àü¼º ÁúȯÀ̶ó°íµµ ÇÑ´Ù. º´, ÀÌ»ó ÇüÁúÀÌ À¯ÀüÀû ¿äÀΰú °ü·ÃÀÌ ÀÖÀ½¿¡ µû¶ó¼­ ¹Ýµå½Ã À¯ÀüÀÚ¿¡ ÀÇÇÏÁö ¾Ê´Â À¯ÀüÀûÀÎ º´µµ À¯Àüº´À̶ó°í ÇÏ°Ô µÇ¾ú´Ù. 1°³ÀÇ ¿ì¼º À¯ÀüÀÚ¿¡ ÀÇÇÏ¿© ÀϾ´Â ÇåÆÃÅÏ ¹«µµº´, ¹ß·»ºÎ¸£Å© ÁõÈıº, ¿­¼º À¯ÀüÀÚÀÇ µ¿Çü Á¢ÇÕ¿¡ ÀÇÇÏ¿© ³ªÅ¸³ª´Â ¹éÀÚ, Æä´ÒÄÉÅæ´¢Áõ, X ¿°»öü À§ÀÇ ¹Ý¼º À¯ÀüÀÚ¿¡ ÀÇÇÑ Àû·Ï »ö¸Í, Ç÷¿ìº´, ÁøÇ༺ ±Ù µð½ºÆ®·ÎÇÇÁõ µîÀº ¸í¹éÈ÷ ÀÌÀ¯ ÀüÀÚ¿¡ ÀÇÇÑ °ÍÀ¸·Î¼­, À¯Àüº´ÀÇ ´ëÇ¥ÀûÀÎ °ÍÀ̶ó°í ÇÒ ¼ö ÀÖ´Ù. ¹Ý¼º À¯ÀüÀÚ´Â X ¿°»öü À§¿¡ À§Ä¡ÇÏ´Â °Í¸¸ ¾Ë·ÁÁ® ÀÖ°í, ³²¼ºÀ» °áÁ¤ÇÏ´Â Y ¿°»öü À§¿¡´Â ÇöÀç±îÁö ƯÈ÷ È®½ÇÇÑ ÇüÁúÀ» °áÁ¤ÇÏ´Â À¯ÀüÀÚ´Â Á¸ÀçÇÏÁö ¾Ê´Â´Ù°í º¸°í ÀÖ´Ù. À¯ÀüÀÚ¿¡ ÀÇÇÑ ÀÌ»óÀ̳ª º´Àº Ãâ»ýÇÏ´Â ¾Æ±âÀÇ 1 %°¡ ÀÌ¹Ì °¡Áö°í Àְųª ¹ßº´ÇÒ °¡´É¼ºÀ» Áö´Ï°í ÀÖ´Ù. ¿°»öüÀÇ ±¸Á¶ ¶Ç´Â ±¸¼ºÀÇ ÀÌ»ó¿¡ ÀÇÇÏ¿© ÀϾ´Â ¿©·¯ °¡Áö ÀÌ»ó ´Ù¿î ÁõÈıº, ÅÍ³Ê ÁõÈıº, Ŭ¶óÀÎÆçÅÍ ÁõÈıº µîµµ ¿°»öü À§¿¡ À¯ÀüÀÚ°¡ ÀÖ´Ù°í ÇÏ´Â Àǹ̿¡¼­´Â À¯ÀüÇÐÀûÀÎ °ÍÀ̶ó°í ÇÒ ¼ö ÀÖ´Ù. ±×·¯³ª ´ë°³´Â ÀÌ»ó °³Ã¼¸¦ ¸¸µç ¹è¿ìÀÚ
  • HIV associated periodontal disease
    HIV¿Í °ü·ÃµÈ Ä¡ÁÖ Áúȯ
  • HIV disease
    ÀÎü ¸é¿ª °áÇÌ ¹ÙÀÌ·¯½º Áúȯ
  • Hodgkin's disease
    È£ÁîŲ º´, È£ÁöŲ º´, Hodgkin º´
    µ¿ÀǾî=malignant lym
  • hunger disease
    ±â¾Æ º´
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
type II mucopolysaccharidosis <syndrome> An error of mucopolysaccharide metabolism characterised by deficiency of iduronate sulfatase, with excretion of dermatan sulfate and heparan sulfate in the urine; clinically similar to Hurler's syndrome but distinguished by less severe skeletal changes, no corneal clouding, and X-linked recessive inheritance.
Synonym: type II mucopolysaccharidosis.
(05 Mar 2000)
type I interferon <chemical> Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (interferon-alpha and interferon-beta).
Pharmacological action: antineoplastic agent, antiviral agents.
(12 Dec 1998)
type I mortality <epidemiology> A mortality schedule in which all hosts are assumed to live for a fixed number of years equal to the life expectancy.
(05 Dec 1998)
type IS mucopolysaccharidosis <syndrome> A hereditary metabolic disorder caused by a recessive gene which results in a deficiency of the enzyme alpha-L-iduronidase, which breaks down dermatan sulphate and heparan sulphate, two types of mucopolysaccharides (complex carbohydrates). Consequently, the mucopolysaccharides accumulate in the cells of the body and cause damage.
Symptoms include skeletal deformities, mental retardation, coronary artery disease, deafness, and stiff joints, among other things. There are mild and severe forms of the syndrome, the severe form is called Hurler syndrome, the mild form is called Scheie Syndrome, and children with an intermediate form have Hurler-Scheie Syndrome. Patients with the mild form generally suffer little to no mental retardation and survive to adulthood. There is presently no cure. Scheie's Syndrome is one of a number of related rare genetic mucopolysaccharide disorders, the most common being Hunter syndrome.
(09 Oct 1997)
type IVA,B mucopolysaccharidosis <syndrome> An error of mucopolysaccharide metabolism with excretion of keratan sulfate in urine; characterised by severe skeletal defects with short stature, severe deformity of spine and thorax, long bones with irregular epiphyses but with shafts of normal length, enlarged joints, flaccid ligaments, and waddling gait; autosomal recessive inheritance; type IV A mucopolysaccharidosis is due to an absence of galactose-1-sulfatase, while type IV B is due to a deficiency of a beta-galactosidase.
Synonym: Brailsford-Morquio disease, Morquio's disease, Morquio-Ullrich disease, type IVA, B mucopolysaccharidosis.
(05 Mar 2000)
type IV acrocephalosyndactyly Acrocephalosyndactyly with pointed nose, hypertelorism, cleft palate, congenital heart disease and pseudohermaphroditism; contractures of elbows and knees; soft tissue syndactyly, absent first metatarsal and great toe. Autosomal recessive.
(05 Mar 2000)
type IV collagen A less distinctly fibrillar form of collagen characteristic of basement membranes.
(05 Mar 2000)
type IV familial hyperlipoproteinaemia Plasma levels of VLDL, pre-beta-lipoproteins and triglycerides are increased on a normal diet, but beta-lipoproteins, cholesterol, and phospholipids are normal; hypertriglyceridemia is induced by a high carbohydrate diet; may be accompanied by abnormal glucose tolerance and susceptibility to ischemic heart disease; probably autosomal recessive inheritance.
Synonym: carbohydrate-induced hyperlipaemia, familial hyperprebetalipoproteinaemia, familial hypertriglyceridemia.
(05 Mar 2000)
type IV prepilin peptidase <enzyme> Product of the pulc-o pullulanase secretion gene operon; involved in processing prepilin signal peptide; may also function as an n-methyltransferase
Registry number: EC 3.4.99.-
Synonym: pulo protein, pulo gene product, pulo peptidase
(26 Jun 1999)
type locality <zoology> The geographical location of the occurrence of the population from which the type specimen was taken. Population occurring at type locality = topotypical population. Specimens collected at type locality = topotypes.
(09 Jan 1998)
type material <zoology> A collective term for all type specimens. Zoologists should ensure that such material is transferred as quickly as possible to public institutions where their safety is guaranteed and they are accessible to other workers.
(09 Jan 1998)
type series <zoology> The series of specimens which either constitutes the name-bearing type of a nominal species or subspecies or from which the name-bearing type has been or may be designated.
(09 Jan 1998)
type species <zoology> The nominal species that is the name-bearing type of a nominal genus or subgenus.
(09 Jan 1998)
type specimen <zoology> Any specimen of the type series.
(09 Jan 1998)
type strain The nomenclatural type of a species or subspecies.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
ÅëÇÕ°Ë»ö ¿Ï·á